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OBJECTIVEdEpidemiological studies have repeatedly investigated the association between
depression and metabolic syndrome (MetS). However, the results have been inconsistent. This
meta-analysis aimed to summarize the current evidence from cross-sectional and prospective
cohort studies that evaluated this association.
RESEARCH DESIGN AND METHODSdMEDLINE, EMBASE, and PsycINFO data-
basesweresearchedforarticlespublisheduptoJanuary2012.Cross-sectionalandcohortstudies
that reported an association between the two conditions in adults were included. Data on prev-
alence, incidence, unadjusted or adjusted odds ratio (OR), and 95% CI were extracted or pro-
vided by the authors. The pooled OR was calculated separately for cross-sectional and cohort
studies using random-effects models. The I
2 statistic was used to assess heterogeneity.
RESULTSdThe search yielded 29 cross-sectional studies (n = 155,333): 27 studies reported
unadjusted OR with a pooled estimate of 1.42 (95% CI 1.28–1.57; I
2 = 55.1%); 11 studies
reported adjusted OR with depression as the outcome (1.27 [1.07–1.57]; I
2 = 60.9%), and 12
studies reported adjusted OR with MetS as the outcome (1.34 [1.18–1.51]; I
2 = 0%). Eleven
cohort studies were found (2 studies reported both directions): 9 studies (n = 26,936 with 2,316
new-onset depressioncase subjects) reportedadjustedORwithdepression astheoutcome(1.49
[1.19–1.87];I
2=56.8%),4studies(n=3,834with350MetScasesubjects)reportedadjustedOR
with MetS as the outcome (1.52 [1.20–1.91]; I
2 = 0%).
CONCLUSIONSdOur results indicate a bidirectional association between depression and
MetS. These results support early detection and management of depression among patients with
MetS and vice versa.
Diabetes Care 35:1171–1180, 2012
D
epression is one of the most com-
mon psychiatric illnesses affecting
adults and is a major public health
problemintheU.S.(1).Agrowingbodyof
evidenceshowsthatdepressionisrelatedto
anincreasedriskofdiabetes(2)andcardio-
vascular disease (CVD) (3). Metabolic syn-
drome (MetS) is a cluster of several CVD
risk factors, including central obesity,
hyperglycemia, elevated blood pressure,
hypertriglyceridemia, and decreased HDL
cholesterol(4).MetSisalsoprevalentinthe
general population (5) and is associated
with an increased risk of diabetes and
CVD (6). Because both depression and
MetS confer signiﬁcant public health chal-
lenges, the association between the two
conditions has attracted attention recently.
A number of epidemiological studies
have been conducted to investigate this
association with inconsistent results re-
ported. In particular, the temporal direc-
tion of this association remains unclear.
We therefore summarized here the avail-
able data from both cross-sectional and
prospectivecohortstudiesandperformed
meta-analyses to investigate the cross-
sectional correlation and longitudinal re-
lation between depression and MetS.
RESEARCH DESIGN AND
METHODS
Data sources
We conducted a systematic literature
search (from the index date of the data-
base up to January 2012) of MEDLINE,
EMBASE, and PsycINFO for studies de-
scribing the association between depres-
sion and MetS. Two search themes were
combined using the Boolean operator
“and.” The ﬁrst theme, depression, com-
binedexplodedversionsofMedicalSubject
Headings (MeSH in MEDLINE) “depres-
sion,”“ depressive disorder,” or “antidepres-
sive agents” and corresponding key words
in titles and/or abstracts. The second
theme, MetS, combined exploded versions
of MeSH terms (in MEDLINE) “insulin
resistance” or “metabolic syndrome X”
and corresponding key words in titles
and/or abstracts. Appropriate modiﬁca-
tions were used for searches in EMBASE
and PsycINFO. No restrictions in the
search strategy were inserted. The detailed
search strategy is available upon request.
In addition, we searched the reference lists
of all identiﬁed relevant publications and
reviews. Experts in this area were also
contacted for potential unpublished data.
Study selection
Two authors (A.P. and N.K.) indepen-
dently assessed literature eligibility, and
discrepancies were resolvedbyconsensus
or determined by a third author (F.B.H.).
Articles were considered for inclusion in
the systematic review if 1)t h ea u t h o r sr e -
porteddatafromanoriginal,peer-reviewed
study (i.e.,not case reports, comments, let-
ters, meeting abstracts, or review articles);
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Pan and Associates2) the study was a cross-sectional or pro-
spective cohort study with a noninstitu-
tional adult population (age .18 years);
3) the authors reported an association
betweenthetwoconditions(prevalence,in-
cidence, unadjusted or adjusted odds ratio
[OR],andits95%CI);and4)thestudywas
published in English. We used broad in-
clusion criteria for studies, including all
deﬁnitions of MetS (National Cholesterol
Education Program Adult Treatment Panel
III [NCEP ATP-III], International Diabetes
Federation [IDF], and deﬁnitions from
other organizations or modiﬁed versions)
(4,7) and depression status (assessed by
self-reported symptom scales, physician/
clinician diagnosis, or structured clinical
diagnostic interview). In the case of multi-
ple publications from the same study, only
the most recent paper or article with a lon-
ger follow-up was included. We evaluated
eligible articles by ﬁrst screening titles or
abstracts followed by a full-text review.
Data extraction
Two authors (A.P. and N.K.) indepen-
dently extracted the following informa-
tion from each study using a predesigned
collectionform:studycharacteristics(study
name, authors, publication year and jour-
nal, study site, number of participants,
and follow-up years for cohort studies),
participants’ characteristics (age range or
mean age and sex composition), depres-
sion and MetS measures, analysis strategy
(statistical models and covariates adjusted
in the models), and results (prevalence,
incidence, unadjusted or adjusted OR,
and 95% CI). We evaluated the study
quality by allocating 1 score for each of
the following aspects: selection bias, stan-
dard measures of exposure and outcome,
participation rate in cross-sectional stud-
ies or follow-up rate in cohort studies, ad-
justment for important confounding
factors (socioeconomic status and lifestyle
variables), and generalizability. Thescores
were summed up and studies were classi-
ﬁed as high versus low quality based on
the median value.
Data synthesis
Separate meta-analyses were conducted
to determine 1) the crude OR of this as-
sociation in cross-sectional studies (since
there is no explicit direction in cross-
sectional studies), 2) the adjusted OR
with MetS as the independent variable in
the original reports of cross-sectional
studies, 3) the adjusted OR with depres-
sion as the independent variable in the
original reports of cross-sectional studies,
4) the OR of baseline MetS status and risk
of incident depression in cohort studies,
and 5)theORofbaselinedepressionstatus
and risk of future MetS in cohort studies.
The OR was used as the common
measure of association across articles in
bothcross-sectionalandcohortstudies.If
the study reported effect size other than
OR, transformation was performed and
the corresponding author was contacted
for unpublished data if possible. To be
consistent across studies, we used binary
variables (yes/no) for both MetS and de-
pression. We did not include studies using
depressive scale as a continuous variable
because the risk estimates were not com-
parable with studies using categorized de-
pression measures.
TheORswerepooledusingtherandom-
effects model that included between-
study heterogeneity, and forest plots were
produced. Heterogeneity was evaluated
by the I
2 statistic, and values of 25, 50,
and 75% are considered to represent low,
medium, and high heterogeneity, respec-
tively (8). The possibility of publication
bias was evaluated using the Begg test
and visual inspection of a funnel plot (9).
Stratiﬁedanalyseswereperformedtoeval-
uate the inﬂuences of selected study qual-
ityandparticipantcharacteristicsonstudy
results (10): sex, mean age at baseline, dif-
ferent deﬁnitions of MetS, depression
measure, continent of origin, and study
quality. All statistical analyses were per-
formed with Stata statistical software ver-
sion 11.0 (StataCorp, College Station,
TX). P values were two-sided with a
signiﬁcance level of 0.05.
RESULTS
Literature search and study selection
A total of 4,231 articles were found from
the three electronic databases. The title
andabstractscreeningbasedonthe afore-
mentioned criteria left us with 422 arti-
cles. After examining those articles in full
text, 375 articles were excluded (Supple-
mentary Fig. 1). Among the remaining 47
articles, 5 articles used continuous varia-
bles for depression scales and 1 article
(11) used an extremely low score (Center
for Epidemiologic Studies–Depression
Scale [CESD]-10 score = 0) to deﬁne the
reference group (the conventional cutoff
is ,10). Because the risk estimates might
be overestimated in this study, it was not
included in the main analysis. However,a
sensitivityanalysisofincludingthisarticle
did not change the results. Two articles
(12,13) used the same samples as the
other two studies (14,15), and articles
with longer follow-up and more detailed
information were retained (14,15). Fi-
nally, 39 articles were included (for the
complete references of the 39 articles,
please see references in Supplementary
Data). One cohort study (16) reported
the baseline cross-sectional association
betweendepressionandMetSandwasin-
cluded in both cross-sectional and cohort
analyses. One cross-sectional study (14)
and 2 cohort studies (16,17) reported re-
sults in both directions. Therefore, 29
cross-sectional studies and 11 cohort stud-
ieswereincludedinthemeta-analysis.One
cohort study (17) is still ongoing, and the
authors provided the most recent unpub-
lished results for our meta-analysis.
Cross-sectional studies of the
association between depression
and MetS
Inthe29 cross-sectionalstudiesshownin
Table1,8studiesusedstructuredorsemi-
structured diagnostic interviews to diag-
nose major depressive disorder according
to the DSM. Nineteen studies assessed de-
pression using self-report symptom scales
(e.g., the Beck Depression Inventory
[BDI], the CESD, or the Patient Health
Questionnaire [PHQ]). Two studies used
both measures to identify depression case
subjects; however, 1 study required meet-
ing both criteria, and the other study re-
quired meeting either criterion. In the
studies that used the self-report symptom
scales, the threshold score for a depression
case subject varied across studies (e.g.,BDI
score $10, $15, $17, or $19 in various
studies). MetS was identiﬁed based on the
NCEPATP-IIIormodiﬁedversionsinmost
studies, while 4 studies adopted IDF crite-
ria or a modiﬁed version. Three studies
were conducted in men, 2 in women, and
the remaining in both sexes. Most studies
were implemented in the U.S. (n =8 )
or European countries (n =1 4 ) ,w i t h3i n
Japan, 2 in Australia, 1 in Brazil, and 1 in
Turkey.
At o t a lo f2 7s t u d i e s( n = 153,298)
provided data on the prevalence of de-
pression in adults with and without
MetS(another2studiesprovidedonlyad-
justed OR and, therefore, were not in-
cluded here). The pooled crude OR
between depression and MetS was 1.42
(95%CI1.28–1.57)withamoderatehetero-
geneitydetected(I
2=55.1%)(Fig.1).No
signiﬁcantpublicationbiaswasdetected
(P = 0.72) (Supplementary Fig. 2A).
Subgroup analyses (Supplementary Table
1) showed signiﬁcant differences by
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Depression and metabolic syndromedepression measures (P for between-group
difference = 0.005) and MetS deﬁnitions
(P for between-group difference = 0.04).
Theassociationwasslightlyweakerwhen
depression was assessed by a diagnostic
interview ratherthan aself-reportedsymp-
tom scale (OR = 1.29 vs. 1.51) and was
notably weaker when MetS was deﬁned ac-
cording to the NECP ATP-III criterion com-
pared with other criteria (OR = 1.38 vs.
1.78). No signiﬁcant between-group
difference was found for continent of
residence, study quality, age category,
and sex.
Most of the studies performed multi-
variate logistic regression to adjust for
potential confounders (Supplementary
Table 2). A total of 11 studies (12 reports
because 1 study reported results separately
for men and women) ran the regression
models using depression as the dependent
variable,andthepooledORwas1.27(95%
CI1.07–1.51)withamoderatetohighhet-
erogeneity detected (I
2 =6 0 . 9 % )( S u p p l e -
mentaryFig.3).Twelve studies (14 reports
because 2 studies reported results sepa-
rately for men and women) used MetS as
thedependentvariable.ThepooledORwas
1.34(1.18–1.51)withnoheterogeneityde-
tected (I
2 = 0%) (Supplementary Fig. 3).
Three studies were excluded because
depressive symptoms score was used as a
continuous variable rather than a binary
variable. Prescott et al. (18) reported that
both men (adjusted OR 1.08 [95% CI
1.05–1.10]) and women (1.04 [1.02–
1 . 0 7 ] )h a da ne l e v a t e dr i s ko fM e t Sf o r
1-unitincreaseof17-itemVitalExhaustion
sum score. Toker et al. (19) reported that
women were atanelevatedriskofMetS for
1-unit increase of PHQ-9 (1.94 [1.22–
3.07]) but not men (1.19 [0.79–1.80]).
Figure 1dForest plot of cross-sectional studies of the crude association between depression and MetS.
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Depression and metabolic syndromeLaudisio et al. (20) reported that MetS was
associated with the Geriatric Depression
Scale score in a multivariate linear regres-
sion analysis in women (b =2 . 1 4[ 9 5 %C I
0.14–4.14]) but not in men (b = –0.84
[23.17 to 1.49]). Therefore, even if these
studies were included, the signiﬁcant asso-
ciation between depression and MetS
would not change.
Cohort studies of MetS predicting
depression risk
Nine cohort studies investigated the asso-
ciation between baseline MetS status and
incidentdepressionwithatotalsamplesize
of 26,936 and 2,316 depression case sub-
jects. Characteristics of the studies are
s h o w ni nT a b l e2 .O ft h en i n es t u d i e s ,
MetS was identiﬁed by the NECP ATP-III
criteria in seven studies, by the IDF criteria
in one study, and by the modiﬁed NECP
ATP-III criteria in one study as a result of
the unavailability of biomarker data. In de-
ﬁning depression, six studies used a self-
reported symptom scale, two studies used
clinical diagnosis–based indicators for de-
pression (one study used a physician diag-
nosis from ICD-10 codes and one used a
structured clinical diagnostic interview),
and one study used a self-reported symp-
tom scale and/or antidepressant medica-
tion use. Participants with depression at
baseline were excluded in all nine studies,
withtwostudiesexcludinglifetimedepres-
sioncasesubjectsandtheothersevenstud-
ies excluding the current depression case
subjects. Two studies were conducted ex-
clusively inmen, one study inwomen, and
six studies were in both sexes with one
study reporting results separately for men
and women. Four studies enrolled par-
ticipants aged .65 years; the other ﬁve
studies enrolled young to middle-aged
groups. Five studies were implemented
in European countries, two in the U.S.,
one in Japan, and one in Australia. The
follow-up ranged from 1 to 10 years.
Thestatisticalmodels,adjustedcovariates,
and results from each study are shown
in Supplementary Table 3.
One study reported the results strati-
ﬁed bysex; therefore, there were10reports
from nine studies. A moderate heteroge-
neity was detected (I
2 = 56.8%), and the
pooled adjusted OR was 1.49 (95% CI
1.19–1.89) (Fig. 2). No publication bias
was detected (P = 0.25) (Supplementary
Fig. 2B). Furthermore, when the diagnos-
tic components of MetS were analyzed
separately (Supplementary Table 4), sig-
niﬁcantpositiveassociationwasfoundbe-
tween central obesity (1.20 [1.07–1.35]),
hypertriglyceridemia (1.20 [1.05–1.38]),
and low HDL concentrations (1.39
[1.19–1.62]) with risk of depression but
not for hyperglycemia (1.05 [0.78–1.42])
and high blood pressure (0.96 [0.72–
1.29]) with risk of depression.
The subgroup analyses are shown in
Supplementary Table 4. We found that
the association was more pronounced in
men(OR=2.15vs.1.66),innon-European
residents (1.69 vs. 1.25), in studies using
diagnostic interview to diagnose depres-
sion (2.18 vs. 1.36), and in studies not
using NECP ATP-III criteria for MetS def-
inition (2.31 vs. 1.28) compared with
their counterparts. However, because of
the limited numbers of studies within sev-
eral subgroups, the results should be in-
terpreted cautiously.
Cohort studies of depression
predicting MetS risk
Four cohort studies investigated the as-
sociation between baseline depression
andfutureriskofMetSwithatotalsample
size of 3,834 and 350 MetS case subjects.
In one study, MetS at baseline was not
assessed, but the results did not change
when baseline obesity or diabetic case
subjects were excluded as speciﬁed in that
study. The characteristics of the studies are
shown in Table 2. Of the four studies, de-
pression was deﬁned by a self-reported
symptom scale in three studies and by di-
agnostic interview in one study. All of the
four studies used the NECP ATP-III crite-
rion or its modiﬁed version to determine
MetS status. Two studies were conducted
in women and two in both sexes with total
and sex-speciﬁc results reported. All four
studies enrolled participants aged ,60
years. Three studies were implemented in
European countries and one in the U.S.
The follow-up ranged from 6 to 17 years.
The pooled adjusted OR was 1.52
(95% CI 1.20–1.91) (Fig. 2) with no het-
erogeneity detected (I
2 = 0%). No publi-
cation bias was detected (P =0 . 5 0 )
(Supplementary Fig. 2C). For the sub-
group analyses (Supplementary Table 5),
the association was stronger in women
(1.72 [1.33–2.23]) but not signiﬁcant in
men (1.03 [0.62–1.69]). No signiﬁcant
differences were found for other stratiﬁed
variables. Two studies reported results for
each component of MetS, and the OR by
baseline depression was marginally signif-
icant only for central obesity (1.31 [0.99–
1.73]) and hypertriglyceridemia (1.28
[0.98–1.67]).
Of note, two articles (21,22) from the
same cohort study were excluded from
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Pan and Associatesthe meta-analysis because depressive
symptoms score (BDI score) was used
as a continuous variable. In the article
with longer follow-up (22), the authors
reported that 1-SD increment in the BDI
score was associated with 29% increased
odds of MetS (OR 1.29 [95% CI 1.04–
1.60]). Thus, our results would not
change if we included this study.
CONCLUSIONSdTo the best of our
knowledge, this is the ﬁrst meta-analysis
that examines the association between
depression and MetS, using data from
both cross-sectional and cohort studies.
We found that depression and MetS were
signiﬁcantly correlated in cross-sectional
studies, and a bidirectional association was
observed in prospective cohort studies.
Most of the cross-sectional studies re-
ported a higher prevalence of depression
in participants with MetS compared with
those without. However, the prevalence
varied signiﬁcantly by sex, study design,
subject sources, and assessment methods
of depression and MetS. Therefore, we
did not pool the prevalence; instead,
pooled the OR, a measure of association
that was more consistent across studies.
Our estimated crude OR was 1.42 (95%
CI 1.28–1.57), suggesting that MetS and
depression are signiﬁcantly related. The
effect size remained signiﬁcant in the
pooled ORs of studies adjusting for po-
tential confounders, such as sociodemo-
graphic factors and lifestyle factors: the
pooled adjusted OR of depression by
MetS status was 1.27 (1.07–1.51), and
the pooled adjusted OR of MetS by de-
pression status was 1.34 (1.18–1.51).
We found that the association was
somewhat stronger in cross-sectional
studies that identiﬁed depression using a
self-reported symptom scale rather than a
structured clinical diagnostic interview or
cliniciandiagnosis.Onepossibleexplana-
tion is that estimates may differ depend-
ing on the use of dimensionally versus
categorically based depression assess-
ment tools (23). Categorically based
toolsdparticularly structured psychiatric
interviewsdwould explicitly exclude in-
dividuals with subsyndromal depressive
symptoms from case status. By contrast,
use of self-reported symptom cutoff scores
wouldallowinclusionofmanypeoplewith
clinically signiﬁcant depressive symptoms
who would not meet formal criteria for
DSM diagnosis, yet abundant evidence in-
dicates that subsyndromal depressive
symptoms, like clinicalsyndromes, aresig-
niﬁcantly associated with morbidity, ad-
verse functional outcomes, and excess
health care use (24). Thus, inclusion of
people with subsyndromal depression in
the reference category may have weakened
estimates of studies using categorically
based depression deﬁnitions. However,
this is in opposition to cohort studies of
MetS predicting depression: participants
with MetS were more likely to develop
clinical diagnosed depression than self-
reported symptoms (OR = 2.18 vs. 1.36).
Nevertheless,onlytwostudiesusedclinical
diagnoseddepression(16,25),andthedef-
inition of MetS in the Almeida et al. (25)
study was stringent (meeting all four crite-
ria of high waist circumference and self-
reportedtreatmentofdyslipidemia,diabetes,
andhypertension).Thus,thisresultshould
be interpreted cautiously. We also found
that the association was stronger in studies
that deﬁned MetS using the IDF criterion
instead of the NCEP ATP-III criterion. The
major distinction between the two criteria
is that the IDF criterion speciﬁes an oblig-
atory component of central obesity, which
is optional in the NCEP ATP-III criterion.
Depression was signiﬁcantly associated
with central obesity (26), which might ex-
plain why the association was stronger
when the IDF deﬁnition was used.
Cross-sectional studies do not provide
the temporal relationship between depres-
sion and MetS. We thus conducted a fur-
ther meta-analysis to investigate the
association between depression and MetS
inprospectivecohortstudies.Thisobserved
bidirectional association between depres-
sion and MetS was consistent with results
from the cross-sectional studies and also in
agreement with two recent meta-analyses
that show a reciprocal association between
depression and diabetes (2) and between
depression and obesity (27).
The interplay between depression
and MetS is likely to be mediated through
multiple mechanisms. First, depression
has been positively associated with cen-
tral obesity (26), chronic inﬂammation
(28), and insulin resistance (29), which
are underlying etiological mechanisms
for MetS (2). Second, depression has
known neuroendocrine effects (e.g., dys-
regulation of the hypothalamic-pituitary-
adrenocorticalaxisandsympatheticnervous
Figure 2dForest plot of prospective studies of the adjusted OR between depression and MetS:
baseline MetS predicting incident depression and baseline depression predicting incident MetS.
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Depression and metabolic syndromesystem activation) (3), which could inﬂu-
ence MetS risk by affecting abdominal fat
accumulation, glucose metabolism, and
blood pressure regulation (30). Third, de-
pressed individuals tend to have poor diet
and sleep disturbance and engage in less
physical activity (31), and these behaviors
areknownriskfactorsforthedevelopment
of MetS. Fourth, conventional medication
treatment for depression may exert direct
effectsonvariouscomponentsofMetSand
partially explain the observed association
(32). In the opposite direction, individuals
with MetS have increased levels of inﬂam-
matory cytokines (e.g., C-reactive protein
andinterleukin6)(5)andleptinresistance
(33), which may also be involved in de-
pressive mood (34,35). Other metabolic
disturbances, such as insulin-glucose
homeostasis and mitochondrial respira-
tion, are also indicated in the pathophysi-
ologyofdepression(36).Anotherpotential
explanation is that vascular damage in the
brainmightpredisposetodepressioninthe
elderly according to the vascular depres-
sion hypothesis (37). MetS, as a cluster of
vascular risk factors, could lead to subclin-
ical vascular damage (38), which in turn
may produce depressive symptoms. Fur-
thermore, MetS is associated with a seden-
tary lifestyle and a negative self-perception
due to stigmatization of obesity (a compo-
nent of MetS), which can lead to an in-
creased risk of depression (27,39). Taken
together, the potential mechanisms are
complex and may involve several shared
physiological pathways, such as obesity
and inﬂammation. Certainly, more studies
are needed to explore the mechanisms un-
derlying thisreciprocalrelation, which will
becrucialfor the prevention andtreatment
of both conditions.
This meta-analysis has strengths and
limitations. The primary strength is that
this is the ﬁrst meta-analysis that explic-
itly examines the bidirectionality of the
depression-MetS relationship on the ba-
sis of a comprehensive literature search.
We contacted authors for unpublished
data and found no indication of publica-
tion bias in all the analyses. However, the
meta-analysis was limited to English-
language publications, and we may have
missed some articles of other languages.
We also observed robust and consistent
associations across different subgroups
via sensitivity analyses and subgroup
analyses. Yet as a major limitation, there
was evidence of heterogeneity across the
studies used for the analysis of association
between MetS and risk of depression in
both study designs. This heterogeneity
may be attributable to the differences in
study design, sample size, analysis strate-
gies, participants’ characteristics, and di-
agnostic criteria of depression and MetS
deﬁnition criteria. To account for the
heterogeneity, we chose random-effects
models for the meta-analyses, but the re-
sults were not materially changed when
weusedﬁxed-effectmodels.Furthermore,
fewcohortstudiesexaminetheassociation
between baseline depression and future
riskofMetSand,thus,moreinvestigations
along this line are needed.
In spite of these limitations, our re-
sults have signiﬁcant implications for
both clinical care and public health.
Mounting evidence suggests that depres-
sion is associated with increased risks of
diabetes(2)andCVD(3).MetSisregarded
as an intermediate condition that fre-
quently proceeds to the clinical manifes-
tations of diabetes and CVD, although
MetS is not usually diagnosed in clinical
settings. Our results suggest that the asso-
ciation between depression and diabetes/
CVD might start at an early stage before
individuals meet the diagnostic criteria of
diabetes or CVD. Therefore, we argue that
in patients with depression, the cardiometa-
bolic risk factors and MetS status should be
carefully monitored, and proper treatment
and lifestyle changes could be advised if the
patientsareatahigherriskofdiabetes/CVD.
Ontheotherhand,forpeoplewithMetSwho
arealreadysusceptibletodiabetes/CVD,early
detection of depression may inform ap-
propriate preventive strategies. Collabo-
rative care for patients with depression
anddiabetes/CVDrecentlyhasbeendem-
onstrated to be effective in control of both
depression and comorbidities (40). Cer-
tainly, more studies are still needed to
evaluate whether early screening and col-
laborative care for patients with depres-
sionandMetS(oritscomponents)could
reducethefutureriskofdiabetes andvascu-
lar diseases.
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